Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Condition(s):DLBCL – Diffuse Large B Cell LymphomaLast Updated:February 9, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):DLBCL – Diffuse Large B Cell LymphomaLast Updated:February 9, 2024Not yet recruiting
Condition(s):Cardiac ArrestLast Updated:January 17, 2024Not yet recruiting
Condition(s):Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Primary Progressive Multiple SclerosisLast Updated:October 5, 2023Recruiting
Condition(s):Cystic Fibrosis; InflammationLast Updated:August 16, 2021Recruiting
Condition(s):Primary Mediastinal LymphomaLast Updated:January 3, 2024Recruiting
Condition(s):Cardiac Arrest; Out-Of-Hospital Cardiac Arrest; Emergency Medical ServicesLast Updated:January 26, 2024Not yet recruiting
Condition(s):Psoriatic Arthritis; Withdrawal; ReductionLast Updated:November 14, 2022Recruiting
Condition(s):Lupus Erythematosus, Systemic; Lupus GlomerulonephritisLast Updated:February 8, 2023Recruiting
Condition(s):PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATLLast Updated:June 16, 2020Recruiting
Condition(s):B Acute Lymphoblastic Leukemia; B Lymphoblastic LymphomaLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.